Literature DB >> 17236237

Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis.

Katja E Andersson1, Geoffrey S Williams, Daniel M Davis, Petter Höglund.   

Abstract

Murine natural killer (NK) cells are inhibited by target cell MHC class I molecules via Ly49 receptors. However, Ly49 receptors can be made inaccessible to target cell MHC class I by a cis interaction with its MHC class I ligand within the NK cell membrane. It has recently been demonstrated that MHC class I proteins transfer from the target cells to the NK cell. Here, we establish that the number of transferred MHC class I proteins is proportional to the number of Ly49A receptors at the NK cell surface. Ly49A+ NK cells from mice expressing the Ly49A ligand H-2D(d) showed a 90% reduction in Ly49A accessibility compared to Ly49A+ NK cells from H-2D(d)-negative mice. The reduction was caused both by lower expression of Ly49A and interactions in cis between Ly49A and H-2D(d) at the NK cell surface. Approximately 75% of the Ly49A receptors on H-2D(d)-expressing NK cells were occupied in cis with endogenous H-2D(d) and only 25% were free to interact with H-2D(d) molecules in trans. Thus, H-2D(d) ligands control Ly49A receptor accessibility through interactions both in cis and in trans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236237     DOI: 10.1002/eji.200636693

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

Review 1.  Current perspectives of natural killer cell education by MHC class I molecules.

Authors:  Petter Höglund; Petter Brodin
Journal:  Nat Rev Immunol       Date:  2010-09-06       Impact factor: 53.106

Review 2.  Cis interactions of immunoreceptors with MHC and non-MHC ligands.

Authors:  Werner Held; Roy A Mariuzza
Journal:  Nat Rev Immunol       Date:  2008-02-29       Impact factor: 53.106

3.  A modified FCCS procedure applied to Ly49A-MHC class I cis-interaction studies in cell membranes.

Authors:  Johan Strömqvist; Sofia Johansson; Lei Xu; Yu Ohsugi; Katja Andersson; Hideki Muto; Masataka Kinjo; Petter Höglund; Jerker Widengren
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

Review 4.  Cis-trans interactions of cell surface receptors: biological roles and structural basis.

Authors:  Werner Held; Roy A Mariuzza
Journal:  Cell Mol Life Sci       Date:  2011-08-24       Impact factor: 9.261

5.  Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.

Authors:  Cathrine A Miner; Tusar K Giri; Claire E Meyer; Mark Shabsovich; Sandeep K Tripathy
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

6.  Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets.

Authors:  Kristin Lampe; Mehari Endale; Siobhan Cashman; Hao Fang; Jochen Mattner; David Hildeman; Kasper Hoebe
Journal:  Eur J Immunol       Date:  2015-05-22       Impact factor: 5.532

7.  Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.

Authors:  Michael D Bern; Diana L Beckman; Takashi Ebihara; Samantha M Taffner; Jennifer Poursine-Laurent; J Michael White; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

Review 8.  Role of PIR-B in autoimmune glomerulonephritis.

Authors:  Toshiyuki Takai; Akira Nakamura; Shota Endo
Journal:  J Biomed Biotechnol       Date:  2010-10-04

9.  MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment.

Authors:  Julie M Elliott; Joseph A Wahle; Wayne M Yokoyama
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

10.  Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.

Authors:  Petter Brodin; Tadepally Lakshmikanth; Ramit Mehr; Maria H Johansson; Adil Doganay Duru; Adnane Achour; Mali Salmon-Divon; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.